104 related articles for article (PubMed ID: 11012736)
21. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
Pyo JS; Kim DH; Yang J
Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
[TBL] [Abstract][Full Text] [Related]
22. Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas.
Katoh R; Miyagi E; Nakamura N; Li X; Suzuki K; Kakudo K; Kobayashi M; Kawaoi A
Hum Pathol; 2000 Mar; 31(3):386-93. PubMed ID: 10746684
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of S100C in thyroid lesions.
Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
[TBL] [Abstract][Full Text] [Related]
24. Expression of c-erbB-2 oncoprotein in human thyroid tumours.
Utrilla JC; Martín-Lacave I; San Martín MV; Fernández-Santos JM; Galera-Davidson H
Histopathology; 1999 Jan; 34(1):60-5. PubMed ID: 9934586
[TBL] [Abstract][Full Text] [Related]
25. CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study.
Prasad ML; Pellegata NS; Kloos RT; Barbacioru C; Huang Y; de la Chapelle A
Thyroid; 2004 Mar; 14(3):169-75. PubMed ID: 15072698
[TBL] [Abstract][Full Text] [Related]
26. Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues.
Chan JY; Chin W; Liew CT; Chang KS; Johnson PJ
Eur J Cancer; 1998 Jun; 34(7):1015-22. PubMed ID: 9849449
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of E-cadherin expression in thyroid neoplasms.
Naito A; Iwase H; Kuzushima T; Nakamura T; Kobayashi S
J Surg Oncol; 2001 Mar; 76(3):176-80. PubMed ID: 11276021
[TBL] [Abstract][Full Text] [Related]
28. Presence of endothelin-1 in the normal and pathological human thyroid.
Lenziardi M; Viacava P; Fiorini I; Castagna M; Nardini V; Pollina L; De Negri F; Goletti O; Di Coscio G; Bevilacqua G
J Endocrinol Invest; 1995 May; 18(5):336-40. PubMed ID: 7594220
[TBL] [Abstract][Full Text] [Related]
29. [The morphological and immunohistochemical features and malignancy potential of a hyalinizing trabecular tumor of the thyroid].
Abrosimov AIu; Dvinskikh NIu; Makanin MA; mal'kov PG; Grinevich VN
Arkh Patol; 2009; 71(6):36-9. PubMed ID: 20131505
[TBL] [Abstract][Full Text] [Related]
30. Reduced expression of retinoic acid receptor beta protein (RAR beta) in human papillary thyroid carcinoma: immunohistochemical and western blot study.
Rochaix P; Monteil-Onteniente S; Rochette-Egly C; Caratero C; Voigt JJ; Jozan S
Histopathology; 1998 Oct; 33(4):337-43. PubMed ID: 9822923
[TBL] [Abstract][Full Text] [Related]
31. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of the suppressor PML and Ki-67 identifies three subtypes of human nasopharyngeal carcinoma.
Chan JY; Meng CL; To KF; Leung SF; Chan AT; Lee KK; Johnson PJ
Eur J Cancer; 2002 Aug; 38(12):1600-6. PubMed ID: 12142048
[TBL] [Abstract][Full Text] [Related]
33. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue.
Serini G; Trusolino L; Saggiorato E; Cremona O; De Rossi M; Angeli A; Orlandi F; Marchisio PC
J Natl Cancer Inst; 1996 Apr; 88(7):442-9. PubMed ID: 8618236
[TBL] [Abstract][Full Text] [Related]
34. Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid.
Arai T; Yamashita T; Urano T; Masunaga A; Itoyama S; Itoh K; Shiku H; Sugawara I
Mod Pathol; 1995 Apr; 8(3):252-6. PubMed ID: 7617649
[TBL] [Abstract][Full Text] [Related]
35. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers.
Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T
Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227
[TBL] [Abstract][Full Text] [Related]
36. [Nuclear DNA in neoplastic pathology of the thyroid gland].
Sussi PL; Azzolina LS; Valerio A; Marchioretto F; Brazzarola P; Angeli G; Davì MV; Stival P; Finchi A; Francia G
Chir Ital; 1994; 46(5):74-6. PubMed ID: 7788816
[TBL] [Abstract][Full Text] [Related]
37. Tissue polypeptide antigen in thyroid tumours of follicular cell origin: an immunohistochemical re-evaluation for diagnostic purposes.
Tuccari G; Barresi G
Histopathology; 1990 Apr; 16(4):377-81. PubMed ID: 2361653
[TBL] [Abstract][Full Text] [Related]
38. Nucleophosmin delocalization in thyroid tumour cells.
Pianta A; Puppin C; Passon N; Franzoni A; Romanello M; Tell G; Di Loreto C; Bulotta S; Russo D; Damante G
Endocr Pathol; 2011 Mar; 22(1):18-23. PubMed ID: 21258971
[TBL] [Abstract][Full Text] [Related]
39. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
Bernet VJ; Anderson J; Vaishnav Y; Solomon B; Adair CF; Saji M; Burman KD; Burch HB; Ringel MD
J Clin Endocrinol Metab; 2002 Oct; 87(10):4792-6. PubMed ID: 12364475
[TBL] [Abstract][Full Text] [Related]
40. [Expression of cell adhesion molecule (CD44V6) in thyroid tumors and its significance].
Li L; Lin L; Qiu J
Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):677-80. PubMed ID: 11769722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]